Sante(SZ:002159)2025-01-24 11:10Financial Performance Forecast - The estimated net profit attributable to shareholders for 2024 is projected to be between 96 million and 144 million CNY, compared to 127.52 million CNY in the same period last year, indicating a potential decrease of 25% to an increase of 13% year-over-year [3]. - The estimated net profit after deducting non-recurring gains and losses is expected to be between 101 million and 149 million CNY, down from 135.95 million CNY in the previous year, reflecting a decrease of 26% to an increase of 10% [3]. - Basic earnings per share are projected to be between 0.54 CNY and 0.81 CNY, compared to 0.72 CNY in the same period last year [3]. Performance Challenges - The decline in performance is primarily attributed to weak consumer demand and intensified industry competition, leading to a decrease in operating revenue [6]. - The company is currently facing legal challenges related to the transfer of equity in a subsidiary, which may impact the annual performance and could lead to results outside the forecast range [7]. Cost Management and Optimization - The company has implemented measures to optimize its asset-liability structure and improve cost management, resulting in significant cost reduction and efficiency gains [6]. Audit and Legal Matters - The company has communicated with its auditing firm regarding the performance forecast, and there are no discrepancies between the two parties [4]. - The performance forecast is based on preliminary estimates and has not yet undergone a pre-audit by the accounting firm [4]. - Investors are advised to make cautious decisions and be aware of investment risks associated with the company's ongoing legal matters [9]. - The company will adjust its financial reporting based on the final audit results and tax department determinations related to the ongoing legal case [8].